Oct 2007 – Data Shows Multiple Sclerosis Lesions Reduced

Announcement Date: October 12, 2007

Oct 12, 2007 – Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy.